ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 76 filers reported holding ARCUS BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,404,000 | -91.3% | 50,000 | -92.0% | 0.01% | -89.1% |
| Q4 2020 | $16,225,000 | +51.5% | 625,000 | 0.0% | 0.13% | +59.3% |
| Q3 2020 | $10,713,000 | -30.7% | 625,000 | 0.0% | 0.08% | -42.6% |
| Q2 2020 | $15,463,000 | +45.2% | 625,000 | -18.5% | 0.14% | -2.1% |
| Q1 2020 | $10,648,000 | +37.4% | 767,128 | 0.0% | 0.14% | +48.5% |
| Q4 2019 | $7,748,000 | +11.0% | 767,128 | 0.0% | 0.10% | +1.0% |
| Q3 2019 | $6,981,000 | +106.6% | 767,128 | +80.5% | 0.10% | +26.3% |
| Q2 2019 | $3,379,000 | -36.3% | 425,000 | 0.0% | 0.08% | -48.6% |
| Q1 2019 | $5,308,000 | +16.0% | 425,000 | 0.0% | 0.15% | -22.1% |
| Q4 2018 | $4,577,000 | – | 425,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,842,077 | $64,233,000 | 17.21% |
| Octagon Capital Advisors LP | 970,164 | $33,830,000 | 8.33% |
| Copernicus Capital Management, LLC | 17,000 | $593,000 | 7.18% |
| EcoR1 Capital, LLC | 5,122,359 | $178,617,000 | 6.21% |
| BVF INC/IL | 3,229,822 | $112,624,000 | 4.39% |
| PFM Health Sciences, LP | 3,431,010 | $119,639,000 | 3.52% |
| Alphabet Inc. | 4,100,475 | $142,984,000 | 3.39% |
| Boxer Capital, LLC | 2,084,883 | $72,700,000 | 2.54% |
| SECTORAL ASSET MANAGEMENT INC | 739,010 | $25,769,000 | 2.14% |
| Parkman Healthcare Partners LLC | 236,637 | $8,252,000 | 2.09% |